ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

著者: American College of Cardiology
  • サマリー

  • The American College of Cardiology offers select interviews and summaries of cardiology’s most interesting research areas from ACCEL’s renowned library, hosted by ACCEL Editor-in-Chief Alison L. Bailey, MD, FACC, FAACPVR.
    American College of Cardiology Foundation. All rights reserved.
    続きを読む 一部表示

あらすじ・解説

The American College of Cardiology offers select interviews and summaries of cardiology’s most interesting research areas from ACCEL’s renowned library, hosted by ACCEL Editor-in-Chief Alison L. Bailey, MD, FACC, FAACPVR.
American College of Cardiology Foundation. All rights reserved.
エピソード
  • Tools of the Trade for HCM: Update in Diagnosis and Management Strategies of a Common Cardiomyopathy
    2025/01/28
    Hypertrophic cardiomyopathy (HCM) is generally an inherited global heart disease in which only a fraction of those with the condition are clinically diagnosed. The recently published HCM guidelines include major changes focusing on medical therapy, increased emphasis exercise testing, management of sudden death risk, and screening for atrial fibrillation. In this interview, Drs. Matthew Martinez and Himabindu Vidula reinforce the importance of these updates for general cardiologists, which aid in identifying HCM patients early and establishing appropriate management plans. Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL 
    続きを読む 一部表示
    13 分
  • The Role of Advanced Lipid Testing in 2024 
    2025/01/21

    Advanced lipid testing holds significant potential in cardiovascular care by enhancing risk prediction beyond standard lipid panels. For patients, this means more tailored treatment and better outcomes by addressing residual risk not captured by traditional LDL-C assessments​. 

     In this interview, Drs. Laxmi Mehta and Michael Shapiro discuss the role and importance of advanced lipid testing. 

     Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL 

    続きを読む 一部表示
    12 分
  • SUMMIT Trial: Tirzepatide for Heart Failure, Preserved Ejection Fraction and Obesity
    2025/01/14

    he SUMMIT trial compared the safety and efficacy of tirzepatide among patients with heart failure with preserved ejection fraction (HFpEF) and obesity. Results from the trial concluded that treatment of obesity reduces major heart failure events in addition to improving health status and exercise tolerance.

    In this interview, Drs. Alison Bailey and Milton Packer examine the power of tirzepatide expanding beyond weight loss and treating diabetes in addition to reducing heart failure events in patients with obesity-related HFpEF.

    Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

    続きを読む 一部表示
    15 分
activate_buybox_copy_target_t1

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Researchに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。